Virtus ETF Advisers’s 2seventy bio TSVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-28,308
Closed -$111K 461
2023
Q3
$111K Sell
28,308
-3,657
-11% -$24K 0.07% 325
2023
Q2
$323K Buy
31,965
+6,923
+28% +$73.3K 0.19% 184
2023
Q1
$255K Buy
25,042
+444
+2% +$5.08K 0.14% 279
2022
Q4
$230K Buy
+24,598
New +$347K 0.12% 310
2022
Q2
Sell
-13,134
Closed -$224K 475
2022
Q1
$224K Hold
13,134
0.1% 192
2021
Q4
$337K Buy
+13,134
New +$410K 0.13% 186

Other funds holding TSVT

Virtus ETF Advisers's TSVT Position: Q4 2023 in Review

Virtus ETF Advisers sold out of 2seventy bio (TSVT) in Q4 2023, closing a stake of 28,308 shares — an estimated $111K sold.

Virtus ETF Advisers first reported a position in TSVT in Q4 2021 and held it in 6 quarters. The position peaked at $337K in Q4 2021. 116 funds tracked by Wall St. Rank hold TSVT as of Q4 2023.

  • Virtus ETF Advisers reported no remaining 2seventy bio position as of Q4 2023 after selling out during the quarter.
  • Virtus ETF Advisers sold 28,308 2seventy bio shares in Q4 2023, an estimated $111K.
  • Virtus ETF Advisers first reported a position in 2seventy bio in Q4 2021 and held it in 6 quarters.
  • Virtus ETF Advisers's 2seventy bio position peaked at $337K in Q4 2021.
  • 116 funds tracked by Wall St. Rank held 2seventy bio as of Q4 2023.

Based on Virtus ETF Advisers's 13F filing for Q4 2023, filed 15 Feb 2024.